Absolute Lymphocyte Count at Day 29 of Treatment Is a Powerful Predictor of Outcome in Multiple Myeloma

Micro-Abstract Multiple myeloma is a malignancy of the bone marrow. Despite advances, the overall prognosis remains poor with median survival of 4-5 years. In a retrospective analysis of 38 patients, we find that the day 29 lymphocyte count, measured four weeks after starting treatment, can powerful...

Ausführliche Beschreibung